CYAN vs. AKAN, SNOA, NMRD, MOTS, GMDA, CPHI, RSLS, CMND, BPTH, and ACON
Should you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Akanda (AKAN), Sonoma Pharmaceuticals (SNOA), Nemaura Medical (NMRD), Motus GI (MOTS), Gamida Cell (GMDA), China Pharma (CPHI), ReShape Lifesciences (RSLS), Clearmind Medicine (CMND), Bio-Path (BPTH), and Aclarion (ACON). These companies are all part of the "medical" sector.
Akanda (NASDAQ:AKAN) and Cyanotech (NASDAQ:CYAN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, community ranking, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.
Akanda has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500. Comparatively, Cyanotech has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500.
Cyanotech received 128 more outperform votes than Akanda when rated by MarketBeat users.
Cyanotech has higher revenue and earnings than Akanda.
In the previous week, Akanda had 2 more articles in the media than Cyanotech. MarketBeat recorded 3 mentions for Akanda and 1 mentions for Cyanotech. Cyanotech's average media sentiment score of 0.34 beat Akanda's score of 0.00 indicating that Akanda is being referred to more favorably in the media.
1.0% of Akanda shares are held by institutional investors. Comparatively, 24.4% of Cyanotech shares are held by institutional investors. 20.4% of Akanda shares are held by insiders. Comparatively, 25.2% of Cyanotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Akanda has a net margin of 0.00% compared to Akanda's net margin of -20.52%. Cyanotech's return on equity of 0.00% beat Akanda's return on equity.
Summary
Akanda beats Cyanotech on 7 of the 12 factors compared between the two stocks.
Get Cyanotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Cyanotech Competitors List
Related Companies and Tools